Shree Ganesh Remedies Ltd (NSE: SGRL), ISIN INE414Y01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SGRL last traded at ₹611.05 (-0.14%), with a 52-week range of ₹381.10 to ₹759.00 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 72.80%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 67/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.